Kathleen A. Wilson-Edell

RPL 24 : a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth

Jason M. Held, C. Benz, C. Yau, 2014 .

RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth

Jason M. Held, C. Benz, C. Yau, 2014, Oncotarget.

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

P. Nelson, C. Benz, P. Kapahi, 2015, Nature Cell Biology.

mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms

C. Benz, Aric N. Rogers, Daniel E. Rothschild, 2014, Breast Cancer Research and Treatment.

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

C. Benz, P. Kapahi, J. Campisi, 2015, Nature Cell Biology.

Author Correction: MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

P. Nelson, C. Benz, P. Kapahi, 2021, Nature Cell Biology.